BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramay FH, Vareedayah AA, Visrodia K, Iyer PG, Wang KK, Eluri S, Shaheen NJ, Reddy R, Martin LW, Greenwald BD, Edwards MA. What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma? Ann Surg Oncol 2019;26:714-31. [DOI: 10.1245/s10434-018-07118-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Sihag S, De La Torre S, Hsu M, Nobel T, Tan KS, Gerdes H, Shah P, Bains M, Jones DR, Molena D. Defining low-risk lesions in early-stage esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2020:S0022-5223(20)33097-X. [PMID: 33334599 DOI: 10.1016/j.jtcvs.2020.10.138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Sesti J, Paul S. Commentary: All that glitters isn't gold: Defining low-risk lesions in early-stage esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2021;162:1280-1. [PMID: 33422305 DOI: 10.1016/j.jtcvs.2020.11.144] [Reference Citation Analysis]
3 Griffin SM, Jones R, Kamarajah SK, Navidi M, Wahed S, Immanuel A, Hayes N, Phillips AW. Evolution of Esophagectomy for Cancer Over 30 Years: Changes in Presentation, Management and Outcomes. Ann Surg Oncol 2021;28:3011-22. [PMID: 33073345 DOI: 10.1245/s10434-020-09200-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]